Acurex Biosciences vs Immitra Bio
Acurex Biosciences vs Immitra Bio, compared side by side on 13 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Acurex Biosciences is on 34/100 and Immitra Bio on 48/100.
Where each one leads
Acurex Biosciences
Leads on none of the measures we hold for both companies.
Immitra Bio
- our overall score: 48/100 against 34/100
- funding raised: $2.6M against $1.0M
At a glance
| Measure | Acurex Biosciences | Immitra Bio |
|---|---|---|
| What it is | Biotechnology company developing new medicines for Parkinson's disease and other neurological disorders. | Scalable, one-time curative in-vivo gene editing therapies. |
| Category | Biotechnology, Pharmaceuticals, Neuroscience, Healthcare | Biotechnology, Gene Therapy, Genetics, Healthcare |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Platform |
| Founded | 2019 | 2024 |
| Headquarters | San Carlos, USA | Zürich, Switzerland |
| Status | Inactive | Active |
Size, funding and growth
| Measure | Acurex Biosciences | Immitra Bio |
|---|---|---|
| Total funding | $1.0M | $2.6M |
| Latest round | Grant | Pre-Seed |
| LinkedIn followers | Not published | 2,336 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Acurex Biosciences | Immitra Bio |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 34/100 | 48/100 |
| Traction | 30/100 | 32/100 |
| Team | Not published | 70/100 |
| Community | 15/100 | Not published |
| Search visibility | 18/100 | 33/100 |
| Quality | 45/100 | 52/100 |
| Agent readinessHow well an AI agent can read and act on the site | Not published | F (29/100) |
| Domain ratingLink authority, 0-100 | Not published | 8/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Acurex Biosciences | Immitra Bio |
|---|---|---|
| CDN | Not detected | Fastly |
| Frameworks | Not detected | Bootstrap |
Acurex Biosciences vs Immitra Bio: common questions
Which is better, Acurex Biosciences or Immitra Bio?
On our 0-100 score Immitra Bio rates higher (48/100 against 34/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 13 data points above: read the rows that match what you are buying for.
How do Acurex Biosciences and Immitra Bio compare on the numbers?
Immitra Bio leads on our overall score (48/100 against 34/100), funding raised ($2.6M against $1.0M).
Read the full Acurex Biosciences review and pricing or the Immitra Bio review and pricing. You can also browse other Acurex Biosciences alternatives we track.